Exploring How and When Does Cabergoline Reduce Pituitary Tumors?
•
4 min read
Dopamine agonists like cabergoline are the first-line treatment for prolactin-secreting pituitary tumors, a condition affecting millions worldwide. This medication, known for its high efficacy and better tolerability compared to older alternatives, can not only normalize prolactin levels but also cause significant tumor shrinkage. This article explores the specific conditions under which **does cabergoline reduce pituitary tumors** and details its mechanism and practical application.
